W
IART icon

Wealthfront’s Integra LifeSciences IART Stock Holding History

Wealthfront’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-374
Closed -$11K – 624
2015
Q3 		$11K Buy
374
+264
+240% +$8.26K ﹤0.01% 925
2015
Q2 		$3K Buy
+110
New +$2.93K ﹤0.01% 1134

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Wealthfront's IART Position: Q4 2015 in Review

Wealthfront sold out of Integra LifeSciences (IART) in Q4 2015, closing a stake of 374 shares — an estimated $11K sold.

Wealthfront first reported a position in IART in Q2 2015 and held it in 2 quarters. The position peaked at $11K in Q3 2015. 186 funds tracked by Wall St. Rank hold IART as of Q4 2015.

  • Wealthfront reported no remaining Integra LifeSciences position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 374 Integra LifeSciences shares in Q4 2015, an estimated $11K.
  • Wealthfront first reported a position in Integra LifeSciences in Q2 2015 and held it in 2 quarters.
  • Wealthfront's Integra LifeSciences position peaked at $11K in Q3 2015.
  • 186 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.